Outcomes Mandate National Integration With Cannabis as Medicine
This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.
Checked against the public recordLast updated Jun 2, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 2
- Sponsor
- OMNI Medical Services, LLC
- Interventions being studied
- Drug: Cannabis, Medical; Device: RYAH-Medtech Inhaler
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Clinical diagnosis of a Qualifying Condition for Medical Marijuana * Must be 18 years or older unless they have consent from their parent or legal guardian as defined under state law parameters * Must be willing to complete online surveys at baseline and the follow up points in this study Exclusion Criteria: * Pregnancy * Breastfeeding * Inability to provide informed consent * Inability to complete study visits or questionnaires * Active suicidality or psychosis, that could be exacerbated by the administration of cannabis
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- OMNI Medical ServicesBoca Raton, Florida
- OMNI Medical ServicesBradenton, Florida
- OMNI Medical ServicesFort Lauderdale, Florida
- OMNI Medical ServicesFort Myers, Florida
- OMNI Medical ServicesGainesville, Florida
- OMNI Medical ServicesMerritt Island, Florida
- OMNI Medical ServicesMiami, Florida
- OMNI Medical ServicesOcoee, Florida
- OMNI Medical ServicesPensacola, Florida
- OMNI Medical ServicesPompano Beach, Florida
- OMNI Medical ServicesTampa, Florida
- OMNI Medical ServicesWesley Chapel, Florida
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 2, 2022. Always confirm current availability with the study team.